- Home
- About Us
- Industry
- Services
- Reading
- Contact Us
Author: Vikas Kumar
July 7, 2022
The chemoinformatics market is expected to register a CAGR of around 13% over the period of 2021-2027.Cheminformatics is a new area of information technology (IT) focused on the collection, storage, analysis, and manipulation of chemical data. Chemical data includes small molecule formulas, structures, properties, spectra, and biological and industrial activities. Cheminformatics helps define archived data logs and depict three-dimensional (3D) molecular structures, further enabling the search and comparison of compounds with specific properties. As a result, it is widely used in the pharmaceutical industry to discover and develop new biotechnology processes and products. Chemoinformatics is being widely utilized in drug discovery & designing, information handling, screening, molecular modeling, analytical chemistry, Quantitative structure-activity relationship (QSAR), and also in polymers, food science, and material science. The applications of this technique are in chemical data collection, representation, analysis, database designing, structure prediction, and building statistical models.
The market will grow significantly due to the increased prevalence of rare diseases and increased investment by private institutions in new drug development. For instance, as per the rare disease organization, approximately 1 in 100,000 people in the United States have Addison’s disease. The overall prevalence is estimated to be between 40 and 60 people per million of the general population. Owing to these glaring statistics the demand for chemoinformatics is anticipated to grow in the forthcoming years. Furthermore, the increasing importance of developing various drug validation techniques and integrating potential drug candidates developed by combinatorial chemistry methods is expected to drive the growth of the chemoinformatics industry during the forecast period.
For a detailed analysis of the Global Chemoinformatics Market browse throughhttps://univdatos.com/report/chemoinformatics-market/
Based on application, the market is classified into drug discovery, chemical analysis, and drug validation. Amongst applications, the chemical analysis category accounted for a significant share of the market. this segment is growing because of the increasing investments in R&D and the relatively low success rate of the potential leads as drug molecules.
Based on end-users, the market is categorized into chemical and pharmaceutical industries, research and academic Institution, and others. Among these, the chemical and pharmaceutical industry is expected to witness the highest CAGR during the forecast period. This is due to the increased demand for personalized medicine, and r&d activities going for new drug discoveries.
Request for Sample of the report browse throughhttps://univdatos.com/get-a-free-sample-form-php/?product_id=22029
For a better understanding of the market adoption of interventional vascular consumables market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the interventional vascular consumables industry in 2020 owing to the presence of well-established market players and the rising R&D activities in the region.
Some of the major players operating in the market include Jubilant Biosys, Molecular Discovery Ltd., OpenEye Scientific Software, Dassault Systemes, Agilent Technologies, Bio-Rad Laboratories, Inc., BioSolveIT GmbH, Schrödinger, LLC, ChemAxon Ltd., Golden Helix, Inc.
Global Chemoinformatics Market Segmentation
Market Insight, by Application
Market Insight, by End-Users
Market Insight, by Region
Top Company Profiles
Get a Callback